Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10668-10681
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10668
Figure 2
Figure 2 Percent of patients with hepatitis C virus RNA. A: Percent of patients with undetectable hepatitis C virus (HCV) RNA treated with transplant viral clearance (TVR) or boceprevir (BOC) plus pegylated-interferon/ribavirin post-liver transplantation[35]; B: Percent of patients on triple therapy (88%, TVR and 12%, BOC) with HCV RNA below level of detection. Sustained viral response rate (SVR4) refers to percent of patients with undetectable HCV RNA 4 wk following completion of 48 wk of treatment[36].